Personal profile
Headline
PROFESSOR
Biography
Fingerprint
Dive into the research topics where Jean-Frédéric Colombel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adherent-invasive Escherichia coli in Crohn’s disease: the 25th anniversary
AIEC Research Group, 1 Feb 2026, In: Gut. 75, 2, p. 411-424 14 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
A pilot genome-wide association study of collagen deposition in collagenous colitis
Di Lorenzo, B., Zheng, T., Rieder, F., Colombel, J. F., Peter, I., Kupcinskas, J., Ohlsson, B., Ferrer Cassado, C., Zabana, Y., Münch, A., Jančiauskas, D., Gordon, I. O., D’Amato, M. & Roda, G., 1 Feb 2026, In: Gastroenterology Report. 14, goaf105.Research output: Contribution to journal › Article › peer-review
Open Access -
Benefit–risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn’s disease
Vermeire, S., Colombel, J. F., Danese, S., Panaccione, R., Peyrin-Biroulet, L., Beck, K., Chaparro, M., Gisbert, J. P., Dubcenco, E., Klaff, J., Naling, G., Ford, S., Remple, V., Joshi, N., Suravaram, S., Duncan, B., Wang, Y., Wick-Urban, B. & Loftus, E. V., 1 Jan 2026, In: Journal of Crohn's and Colitis. 20, 1, jjaf198.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trial
Keefer, L., Ungaro, R., Lewis, A., Lee, J., de Amorrortu, C., Lores, T., Siganporia, T., Mehandru, S., Petralia, F. & Colombel, J. F., Jan 2026, In: Contemporary Clinical Trials. 160, 108151.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn’s Disease: A Systematic Literature Review and Network Meta-Analysis
Schreiber, S., Danese, S., Colombel, J. F., Hisamatsu, T., Irving, P. M., Park, H., Kim, D. H., Lee, Y. N. & Hanauer, S. B., Mar 2026, In: Advances in Therapy. 43, 3, p. 1016-1033 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations
Press/Media
-
Lilly's Omvoh is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years
5/05/26 → 8/05/26
8 items of Media coverage
Press/Media
-
Mirikizumab Demonstrates Sustained Disease Clearance Through 4 Years in Ulcerative Colitis
7/05/26
1 item of Media coverage
Press/Media
-
Lilly’s Omvoh demonstrates durable disease clearance in ulcerative colitis through four years
5/05/26 → 6/05/26
2 items of Media coverage
Press/Media
-
Lilly's Omvoh is the first and only IL─23p19 to demonstrate durable disease clearance in ulcerative colitis through four years
6/05/26
1 item of Media coverage
Press/Media
-
Mirikizumab Maintains Disease Clearance in UC Through 4 Years in LUCENT-3 Extension
5/05/26
1 item of Media coverage
Press/Media